Butler John P.

Average Profitability
<0.0001%
Insider Buys Quantity
6
Insider Buys Sum
$905,149.20
Insider Sells Quantity
9
Insider Sells Sum
$675,951.02

Insider Activity of Butler John P.

According to the SEC Form 4 filings, Butler John P., being in a position of

  1. CEO and President at Akebia Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 130792 shares for $209,036,
    over all time since 2014-03-25, has bought 135700 shares for $905,149, and sold 394417 shares for $675,951.

The largest purchase of all time was on 2014-03-25 and amounted to 27700 shares of Akebia Therapeutics, Inc. for $470,900.

The largest sale of all time was on 2021-03-01 and amounted to 49990 shares of Akebia Therapeutics, Inc. for $169,771.

Biography of Butler John P.

No biography is available at this moment.

2024-02-29SaleAkebia Therapeutics, Inc.
AKBA
CEO and President
46,570
0.0249%
$1.58$73,581-12.74%
2024-02-27SaleAkebia Therapeutics, Inc.
AKBA
CEO and President
37,733
0.0186%
$1.52$57,354-16.46%
2024-02-01SaleAkebia Therapeutics, Inc.
AKBA
CEO and President
46,489
0.0254%
$1.68$78,102-18.42%
2023-03-01SaleAkebia Therapeutics, Inc.
AKBA
CEO and President
91,868
0.0482%
$0.88$80,614+23.5%
2023-02-27SaleAkebia Therapeutics, Inc.
AKBA
CEO and President
38,632
0.0211%
$0.81$31,416+38.48%
2022-03-01SaleAkebia Therapeutics, Inc.
AKBA
CEO and President
53,973
0.0303%
$2.17$117,159-80.93%
2022-02-28SaleAkebia Therapeutics, Inc.
AKBA
CEO and President
25,053
0.0139%
$2.15$53,984-81.02%
2021-04-01SaleAkebia Therapeutics, Inc.
AKBA
CEO and President
4,109
0.0026%
$3.40$13,971-15.92%
2021-03-01SaleAkebia Therapeutics, Inc.
AKBA
CEO and President
49,990
0.0328%
$3.40$169,771-14.71%
2019-11-20PurchaseAkebia Therapeutics, Inc.
AKBA
CEO and President
100,000
0.087%
$3.44$344,000+130.84%
2014-12-29PurchaseAkebia Therapeutics, Inc.
AKBA
CEO and President
2,000
0.0102%
$11.57$23,134-15.05%
2014-12-22PurchaseAkebia Therapeutics, Inc.
AKBA
CEO and President
2,000
0.0097%
$11.92$23,832-21.16%
2014-12-15PurchaseAkebia Therapeutics, Inc.
AKBA
CEO and President
2,000
0.0107%
$11.34$22,673-8.88%
2014-11-12PurchaseAkebia Therapeutics, Inc.
AKBA
CEO and President
2,000
0.0084%
$10.30$20,610-19.78%
2014-03-25PurchaseAkebia Therapeutics, Inc.
AKBA
President and CEO
27,700
1.0572%
$17.00$470,900+3.17%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.